Skip to main content

Role of Branched Chain Amino Acids in Cellular and Organ Damage: The Prognostic Significance of the Preoperative Branched Chain Amino Acid to Tyrosine Ratio

  • Chapter
  • First Online:
Branched Chain Amino Acids in Clinical Nutrition

Abstract

Amino acid (AA) ratios are indicative of the systemic balance between protein metabolism and catabolism. The question arises as to whether particular AA ratios reflect the severity of liver damage. This chapter examines the relationship between preoperative AA ratios and liver function in hepatocellular carcinoma (HCC) patients. In addition, we discuss the clinical value of AA ratios in HCC patients who elect to undergo surgery. The branched-chain amino acid to tyrosine ratio (BTR) is an alternative indicator for Fischer’s ratio. The correlation between the Fischer’s ratio and the BTR is very high. In addition, the correlation between the BTR and other liver functional indicators varied depending on the severity of the patient’s liver disease. The BTR was not only able to predict the risk of complications but also predicted the severity of complications after initial hepatectomy for HCC. Furthermore, BTR was able to predict both recurrence free-survival (RFS) and overall survival (OS). The BTR-ALB classification could be used to identify patient groups that would benefit from branched-chain amino acid (BCAA) supplementation as adjuvant nutritional support.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tom A, Nair KS. Assessment of branched-chain amino Acid status and potential for biomarkers. J Nutr. 2006;136:324S–30.

    CAS  PubMed  Google Scholar 

  2. Ishikawa T. Branched-chain amino acids to tyrosine ratio value as a potential prognostic factor for hepatocellular carcinoma. World J Gastroenterol. 2012;18:2005–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Kawaguchi T, Izumi N, Charlton MR, Sata M. Branched-chain amino acids as pharmacological nutrients in chronic liver disease. Hepatology. 2011;54:1063–70.

    Article  CAS  PubMed  Google Scholar 

  4. Dejong CH, van de Poll MC, Soeters PB, Jalan R, Olde Damink SW. Aromatic amino acid metabolism during liver failure. J Nutr. 2007;137:1579S–85. discussion 1597S-1598S.

    CAS  PubMed  Google Scholar 

  5. de Lope CR, Tremosini S, Forner A, Reig M, Bruix J. Management of HCC. J Hepatol. 2012;56 Suppl 1:S75–87.

    Article  PubMed  Google Scholar 

  6. Cauchy F, Fuks D, Belghiti J. HCC: current surgical treatment concepts. Langenbecks Arch Surg. 2012;397:681–95.

    Article  CAS  PubMed  Google Scholar 

  7. Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 2010;7:448–58.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Michitaka K, Hiraoka A, Kume M, Uehara T, Hidaka S, Ninomiya T, et al. Amino acid imbalance in patients with chronic liver diseases. Hepatol Res. 2010;40:393–8.

    Article  CAS  PubMed  Google Scholar 

  9. Carli F, Webster J, Ramachandra V, Pearson M, Read M, Ford GC, et al. Aspects of protein metabolism after elective surgery in patients receiving constant nutritional support. Clin Sci (Lond). 1990;78:621–8.

    CAS  Google Scholar 

  10. Fabregat I, Roncero C, Fernandez M. Survival and apoptosis: a dysregulated balance in liver cancer. Liver Int. 2007;27:155–62.

    Article  CAS  PubMed  Google Scholar 

  11. Schon MR, Heil W, Lemmens HP, Padval D, Matthes M, Puhl G, et al. Xenogeneic, extracorporeal liver perfusion in primates improves the ratio of branched-chain amino acids to aromatic amino acids (Fischer’s ratio). Eur Surg Res. 1999;31:230–9.

    Article  CAS  PubMed  Google Scholar 

  12. Soeters PB, Fischer JE. Insulin, glucagon, aminoacid imbalance, and hepatic encephalopathy. Lancet. 1976;2:880–2.

    Article  CAS  PubMed  Google Scholar 

  13. James JH, Ziparo V, Jeppsson B, Fischer JE. Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy. Lancet. 1979;2:772–5.

    Article  CAS  PubMed  Google Scholar 

  14. Loda M, Clowes Jr GH, Nespoli A, Bigatello L, Birkett DH, Menzoian JO. Encephalopathy, oxygen consumption, visceral amino acid clearance, and mortality in cirrhotic surgical patients. Am J Surg. 1984;147:542–50.

    Article  CAS  PubMed  Google Scholar 

  15. Azuma Y, Maekawa M, Kuwabara Y, Nakajima T, Taniguchi K, Kanno T. Determination of branched-chain amino acids and tyrosine in serum of patients with various hepatic diseases, and its clinical usefulness. Clin Chem. 1989;35:1399–403.

    CAS  PubMed  Google Scholar 

  16. Yang J, He J, Cao H, Zhao X, Fu S, Lu H, et al. Correlation between plasma amino acid profiles and the various stages of hepatitis B infection. Eur J Clin Microbiol Infect Dis. 2012;31:2045–52.

    Article  CAS  PubMed  Google Scholar 

  17. Shimizu H, Taniguchi K, Sugiyama M, Kanno T. Rapid enzymatic analysis of plasma for tyrosine. Clin Chem. 1990;36:32–5.

    CAS  PubMed  Google Scholar 

  18. Niguma T, Yumura M, Yamasita Y, Maeda K, Kimura T, Yamamura M, et al. Ratio of branched chain amino acid to tyrosine after hepatectomy. Surg Today. 1999;29:825–7.

    Article  CAS  PubMed  Google Scholar 

  19. Mizuguchi T, Kawamoto M, Meguro M, Nakamura Y, Harada K, Kukita K, et al. Prognostic impact of preoperative the branched-chain amino acid to the tyrosine ratio in hepatocellular carcinoma patients after initial hepatectomy. J Gastrointest Surg. 2011;15:1433–9.

    Article  PubMed  Google Scholar 

  20. Nakamura Y, Mizuguchi T, Kawamoto M, Meguro M, Harada K, Ota S, et al. Cluster analysis of indicators of liver functional and preoperative low branched-chain amino acid tyrosine ration indicate a high risk of early recurrence in analysis of 165 hepatocellular carcinoma patients after initial hepatectomy. Surgery. 2011;150:250–62.

    Article  PubMed  Google Scholar 

  21. van Malenstein H, van Pelt J, Verslype C. Molecular classification of hepatocellular carcinoma anno 2011. Eur J Cancer. 2011;47:1789–97.

    Article  PubMed  Google Scholar 

  22. Mizuguchi T, Nagayama M, Meguro M, Shibata T, Kaji S, Nobuoka T, et al. Prognostic impact of surgical complications and preoperative serum hepatocyte growth factor in hepatocellular carcinoma patients after initial hepatectomy. J Gastrointest Surg. 2009;13:325–33.

    Article  PubMed  Google Scholar 

  23. Benzoni E, Cojutti A, Lorenzin D, Adani GL, Baccarani U, Favero A, et al. Liver resective surgery: a multivariate analysis of postoperative outcome and complication. Langenbecks Arch Surg. 2007;392:45–54.

    Article  PubMed  Google Scholar 

  24. Yeh CN, Chen MF, Lee WC, Jeng LB. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol. 2002;81:195–202.

    Article  PubMed  Google Scholar 

  25. Mizuguchi T, Mitaka T, Kojima T, Hirata K, Nakamura T, Mochizuki Y. Recovery of mRNA expression of tryptophan 2,3-dioxygenase and serine dehydratase in long-term cultures of primary rat hepatocytes. J Biochem. 1996;120:511–7.

    Article  CAS  PubMed  Google Scholar 

  26. Mizuguchi T, Mitaka T, Hirata K, Oda H, Mochizuki Y. Alteration of expression of liver-enriched transcription factors in the transition between growth and differentiation of primary cultured rat hepatocytes. J Cell Physiol. 1998;174:273–84.

    Article  CAS  PubMed  Google Scholar 

  27. Lee ST, Tan T, Poon AM, Toh HB, Gill S, Berlangieri SU, et al. Role of low-dose, noncontrast computed tomography from integrated positron emission tomography/computed tomography in evaluating incidental 2-deoxy-2-[F-18]fluoro-D-glucose-avid colon lesions. Mol Imaging Biol. 2008;10:48–53.

    Article  CAS  PubMed  Google Scholar 

  28. Matthews DE. Observations of branched-chain amino acid administration in humans. J Nutr. 2005;135:1580S–4.

    CAS  PubMed Central  PubMed  Google Scholar 

  29. Fan ST, Lo CM, Lai EC, Chu KM, Liu CL, Wong J. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med. 1994;331:1547–52.

    Article  CAS  PubMed  Google Scholar 

  30. Kawamura E, Habu D, Morikawa H, Enomoto M, Kawabe J, Tamori A, et al. A randomized pilot trial of oral branched-chain amino acids in early cirrhosis: validation using prognostic markers for pre-liver transplant status. Liver Transpl. 2009;15:790–7.

    Article  PubMed  Google Scholar 

  31. Waterhouse C. How tumors affect host metabolism. Ann N Y Acad Sci. 1974;230:86–93.

    Article  CAS  PubMed  Google Scholar 

  32. Baracos VE, Mackenzie ML. Investigations of branched-chain amino acids and their metabolites in animal models of cancer. J Nutr. 2006;136:237S–42.

    CAS  PubMed  Google Scholar 

  33. Kawamura I, Moldawer LL, Keenan RA, Batist G, Bothe Jr A, Bistrian BR, et al. Altered amino acid kinetics in rats with progressive tumor growth. Cancer Res. 1982;42:824–9.

    CAS  PubMed  Google Scholar 

  34. Freund HR, Ryan Jr JA, Fischer JE. Amino acid derangements in patients with sepsis: treatment with branched chain amino acid rich infusions. Ann Surg. 1978;188:423–30.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Freund H, Atamian S, Holroyde J, Fischer JE. Plasma amino acids as predictors of the severity and outcome of sepsis. Ann Surg. 1979;190:571–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Toru Mizuguchi M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Mizuguchi, T., Mitaka, T., Hirata, K. (2015). Role of Branched Chain Amino Acids in Cellular and Organ Damage: The Prognostic Significance of the Preoperative Branched Chain Amino Acid to Tyrosine Ratio. In: Rajendram, R., Preedy, V., Patel, V. (eds) Branched Chain Amino Acids in Clinical Nutrition. Nutrition and Health. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1914-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1914-7_5

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-1913-0

  • Online ISBN: 978-1-4939-1914-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics